Loading...
14 Asia Inhibitors Reports
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: AstraZeneca, Eli Lilly and Company, Merck, Novartis, Bristol-Myers Squibb
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand
Major Players: Takeda Pharmaceuticals, Pfizer, Bayer, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie, Johnson & Johnson, Novartis, Eli Lilly and Company, GlaxoSmithKline
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, India, China, Japan, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, AstraZeneca, Bayer, Boehringer Ingelheim, Amgen
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Boehringer Ingelheim, Roche, AstraZeneca, Novartis, Bayer
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer, Pfizer, Takeda Pharmaceuticals, Zydus Group, AstraZeneca
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb, Regeneron Pharmaceuticals, AstraZeneca, Roche, Merck
Region Covered: Asia
Study Period: 2020 - 2030
Countries Covered: Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: CSL Behring, Takeda Pharmaceuticals, Pharming Technologies B.V., KalVista Pharmaceuticals, BioCryst Pharmaceuticals
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teva Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Daiichi Sankyo, Sun Pharmaceuticals Industries
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Eli Lilly and Company
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Sun Pharmaceuticals Industries, Novartis, Teva Pharmaceutical Industries, Mylan, Dr. Reddy’s Laboratories
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: UCB, Pfizer, Johnson & Johnson, Amgen, Abbvie
Filter Reports
By Countries
